tradingkey.logo
搜尋

Seer Inc

SEER
添加自選
1.690USD
+0.030+1.81%
收盤 06/26, 16:00美東報價延遲15分鐘
93.06M總市值
虧損本益比TTM

Seer Inc

1.690
+0.030+1.81%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.81%

5天

-2.87%

1月

-12.44%

6月

-8.15%

今年開始到現在

-7.65%

1年

-20.28%

關鍵數據
1.720今開
1.757最高
10.00成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.00%換手率
1.660昨收
1.660最低
17.00成交額
虧損本益比靜
0.39市淨率
0.00%股息率 TTM
-22.76%ROA
2.41052週最高
-0.00量比
-86.60M淨利潤
55.07M總股本
-1.2461每股盈餘TTM
1.61Beta
-25.52%ROE
1.65052週最低
5.86%振幅
35.16%毛利率
93.06M總市值
-4.97回報/風險
2.26%風險率

TradingKey Seer Inc股票評分

單位: USD 更新時間: 2026-06-26

操作建議

Seer Inc當前公司基本面數據相對非常健康,增長潛力穩定。當前估值合理,在辦公設備行業排名6/7位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為4.00。中期看,股價處於平穩狀態。近一個月,市場表現較差,但技術面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Seer Inc評分

相關信息

行業排名
6 / 7
全市場排名
274 / 4566
所屬行業
辦公設備

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
極度看空

Seer Inc亮點

亮點風險
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
業績增長期
公司處於發展階段,最新年度總收入16.58M美元
估值合理
公司最新PB估值0.38,處於3年歷史合理位
機構減倉
最新機構持股29.42M股,環比減少20.92%
史蒂文·科恩持倉
明星投資者史蒂文·科恩持倉,最新持倉13.17K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.45

分析師目標

基於 2 分析師
買入
評級
4.000
目標均價
+140.96%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Seer Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Seer Inc簡介

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
公司代碼SEER
公司Seer Inc
CEOFarokhzad (Omid C)
網址https://seer.bio/

常見問題

Seer Inc(SEER)的當前股價是多少?

Seer Inc(SEER)的當前股價是 1.66。

Seer Inc 的股票代碼是什麼?

Seer Inc的股票代碼是SEER。

Seer Inc股票的52週最高點是多少?

Seer Inc股票的52週最高點是2.41。

Seer Inc股票的52週最低點是多少?

Seer Inc股票的52週最低點是1.65。

Seer Inc的市值是多少?

Seer Inc的市值是91.27M。

現在Seer Inc(SEER)的股票是買入、持有還是賣出?

根據分析師評級,Seer Inc(SEER)的總體評級為買入,目標價格為4.00。

Seer Inc(SEER)股票的每股收益(EPS TTM)是多少

Seer Inc(SEER)股票的每股收益(EPS TTM)是-1.28。
KeyAI